The time-series behavior of neutrophil-to-lymphocyte ratio is useful as a predictive marker in non-small cell lung cancer-Reference-Cited by-同舟云学术

The time-series behavior of neutrophil-to-lymphocyte ratio is useful as a predictive marker in non-small cell lung cancer

Published:2018-02-15 Issue:2 Volume:13 Page:e0193018
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kiriu Tatsunori,Yamamoto Masatsugu^ORCID,Nagano Tatsuya,Hazama Daisuke,Sekiya Reina,Katsurada Masahiro,Tamura Daisuke,Tachihara Motoko,Kobayashi Kazuyuki,Nishimura Yoshihiro

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference26 articles.

1. Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer;H Borghaei;N Engl J Med,2015

2. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer;J Brahmer;N Engl J Med,2015

3. Inflammation and cancer;LM Coussens;Nature,2002

4. Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation;S Rivas-Fuentes;J Cancer,2015

5. Ratio of neutrophil to lymphocyte counts—rapid and simple parameter of systemic inflammation and stress in critically ill;R Zahorec;Bratisl Lek Listy,2001

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy;Current Oncology;2024-08-26

2. Derived neutrophil-to-lymphocyte ratio has the potential to predict safety and outcomes of durvalumab after chemoradiation in non-small cell lung cancer;Scientific Reports;2024-08-23

3. Predictors of Immunotherapy Efficacy in Metastatic Non-Small Cell Lung Cancer: Lung Immune Prognostic Index and Immune-Related Toxicity;World Journal of Oncology;2024-04

4. Inflammatory markers predict survival in patients with postoperative urothelial carcinoma receiving tislelizumab (PD-1 inhibitor) adjuvant therapy;BMC Cancer;2024-02-12

5. SLC7A8 overexpression inhibits the growth and metastasis of lung adenocarcinoma and is correlated with a dismal prognosis;Aging;2024-01-18